Press Release May 27 2022
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its injectables manufacturing facility at Jarod. The report indicates that the facility's inspection classification is Voluntary Action Indicated, and the inspection is considered closed. This inspection was a Pre-Approval cum cGMP inspection covering multiple Abbreviated New Drug Applications.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release May 26 2022
- Press Release May 13 2022
- Press Release May 06 2022
- Press Release May 03 2022
- Press Release Apr 26 2022
Later from Zydus Lifesciences
- Press Release Jun 06 2022
- Press Release Jun 07 2022
- Press Release Jun 30 2022
- Press Release Jul 08 2022
- Press Release Jul 11 2022
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences